Applied UV, Inc. (AUVI) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Applied UV, Inc. (AUVI) trades at $0.0003 with AI Score 51/100 (Grade B). Applied UV, Inc. develops and commercializes air purification and infection control technologies, alongside manufacturing decorative mirrors and bathroom vanities. Sector: Consumer cyclical.
Price as of Jul 20, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for AUVI: AUVI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AUVI against Consumer Cyclical peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
AUVI: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Applied UV, Inc. (AUVI) Consumer Business Overview
Applied UV, Inc. operates in the Consumer Cyclical sector, specializing in science-based air purification and hard surface disinfection solutions under brands like Airocide and Lumicide. Concurrently, it maintains a presence in the hospitality market through decorative mirrors and bathroom vanities, serving diverse markets across North America and Europe.
What Is the Investment Thesis for AUVI?
Applied UV, Inc. presents a unique market position by combining infection control technologies with a hospitality furnishings segment, operating across the U.S., Canada, and Europe. The company's focus on science-based solutions under brands like Airocide and Lumicide positions it within growing markets for health and safety, particularly relevant in healthcare and commercial sectors. However, the company currently operates with a significant negative profit margin of -32.4% and a gross margin of 19.2%, indicating challenges in achieving profitability despite its market presence. The reported market capitalization of $0.00B suggests a very small or negligible public valuation, which implies substantial financial risk and potential liquidity concerns. Future growth catalysts could stem from increased adoption of its disinfection technologies in response to public health demands and potential expansion within the hospitality sector as travel and leisure recover. The company's negative Beta of -1.10 is unusual and could suggest an inverse correlation to market movements or reflect low trading volume and volatility, warranting careful consideration for investors evaluating market risk exposure. The company's ability to scale its operations, improve cost efficiencies, and convert its technology into sustainable revenue streams will be critical for long-term value creation.
Based on FMP financials and quantitative analysis
AUVI Key Highlights
- Applied UV, Inc. operates with a negative profit margin of -32.4%, indicating the company is not currently profitable.
- The company maintains a gross margin of 19.2%, reflecting the profitability of its core sales before operating expenses.
- Applied UV, Inc. has a reported market capitalization of $0.00B, suggesting a very low or negligible public valuation.
- The company's Beta is -1.10, an unusual figure that may indicate an inverse relationship with market movements or specific trading dynamics.
- Applied UV, Inc. has 131 employees, supporting its dual operations in disinfection technology and hospitality furnishings.
Who Are AUVI's Competitors?
AUVI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DGIX Dyna Group International Inc. | $0.84 | +0.00% | $6.41M | 46 |
| NTZ Natuzzi S.p.A. | $1.55 | -0.64% | $17.1M | 45 |
| CRWS Crown Crafts, Inc. | $3.01 | +0.67% | $32.4M | 69 |
| VIOT Viomi Technology Co., Ltd | $0.81 | -2.28% | $55.0M | 46 |
| WKGBF Sanderson Design Group plc | $1.01 | +0.00% | $73.0M | 51 |
| NVFY Nova LifeStyle, Inc. | $6.18 | -0.80% | $85.2M | 51 |
| VCCTF Victoria PLC | $0.87 | +0.00% | $100M | 43 |
| KEQU Kewaunee Scientific Corporation | $36.26 | -4.85% | $104M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AUVI's Key Strengths?
- Diversified business model with two distinct segments: Disinfection and Hospitality.
- Proprietary science-based solutions for air purification (Airocide) and hard surface disinfection (Lumicide).
- Established market presence in the United States, Canada, and Europe.
- Ability to address critical needs in healthcare, hospitality, commercial, municipal, and residential markets.
- Track record of developing and acquiring technology to expand its offerings.
What Are AUVI's Weaknesses?
- Significant negative profit margin of -32.4%, indicating unprofitability.
- Low gross margin of 19.2% suggests limited profitability from core sales.
- Reported market capitalization of $0.00B implies very limited public valuation and potential liquidity issues.
- Negative Beta of -1.10, which can be indicative of unusual market dynamics or high risk.
- Reliance on consumer cyclical markets for its hospitality segment, making it vulnerable to economic downturns.
What Could Drive AUVI Stock Higher?
- Potential strategic acquisitions that could expand the company's technology portfolio or market reach, offering new revenue streams and synergistic benefits.
- Continued development and commercialization of new science-based air purification and hard surface disinfection products, driving adoption in healthcare and commercial markets.
- Recovery and sustained growth in the hospitality sector, leading to increased demand for decorative framed mirrors, framed arts, and bathroom vanities.
- Expansion of sales and distribution channels in existing markets across the United States, Canada, and Europe, aiming to increase market penetration for both segments.
What Are the Key Risks for AUVI?
- Financial-distress signal — its Altman Z-Score of -1.21 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-62.7%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Persistent negative profit margin of -32.4% indicates a challenge in achieving profitability, which could impact long-term financial stability and investor confidence.
- Intense competition in both the disinfection technology and hospitality furnishings markets could pressure pricing and market share, affecting revenue growth.
- Economic downturns or reduced consumer spending could significantly impact the demand for products in the consumer cyclical hospitality segment.
- The reported market capitalization of $0.00B suggests very limited public valuation and potential liquidity concerns for investors.
- Integration risks associated with future acquisitions, including challenges in combining operations, cultures, and technologies, which could hinder expected synergies.
What Are the Growth Opportunities for AUVI?
- **Expansion in the Air Purification Market:** The global air purification market is projected to continue its growth trajectory, driven by increasing concerns over indoor air quality, pollution, and airborne pathogens. Applied UV, Inc.'s Airocide brand, with its science-based solutions, is well-positioned to capitalize on this trend. Expanding its reach within existing healthcare, commercial, and municipal markets, and penetrating new residential segments, could significantly increase revenue.
- **Leveraging Hard Surface Disinfection Demand:** The demand for effective hard surface disinfection solutions remains robust across all sectors, particularly in healthcare and hospitality, where stringent hygiene standards are paramount. Applied UV, Inc.'s Lumicide brand can capitalize on this ongoing need by developing and marketing new products that offer superior efficacy and ease of use. Strategic partnerships with large commercial cleaning services or healthcare facility management groups could accelerate adoption. This market segment is expected to see consistent demand over the next 3-5 years, supported by heightened public awareness and institutional protocols.
- **Growth in the Hospitality Furnishings Segment:** As the hospitality sector continues its recovery and expansion, particularly in North America and Europe, the demand for high-quality decorative framed mirrors, framed arts, and bathroom vanities is expected to rise. Applied UV, Inc.'s existing manufacturing capabilities and supply chain for these products position it to capture a larger share of this market. Focusing on design innovation, customization options, and strengthening relationships with hotel chains and interior designers could drive significant revenue growth within this segment over the next 2-4 years.
- **Geographic Market Penetration:** Applied UV, Inc. currently operates in the United States, Canada, and Europe. There is significant opportunity to deepen its market penetration within these existing regions by expanding sales channels, increasing brand awareness, and tailoring products to specific regional demands. Furthermore, exploring new international markets with high growth potential for both disinfection technologies and hospitality furnishings could unlock substantial long-term growth. Strategic market entry could involve partnerships or direct sales efforts over the next 3-7 years.
- **Strategic Acquisitions and Technology Integration:** The company's stated strategy includes developing, acquiring, and commercializing technology. Pursuing strategic acquisitions of complementary technologies or companies could accelerate its market entry into new niches, enhance its product portfolio, and consolidate its position in existing markets. Integrating acquired technologies, particularly in the disinfection space, could lead to synergistic benefits, improved R&D capabilities, and expanded intellectual property. This inorganic growth strategy could provide significant catalysts for revenue and market share expansion over a 1-5 year horizon.
What Opportunities Does AUVI Have?
- Growing global demand for air purification and infection control technologies across all sectors.
- Recovery and expansion of the hospitality sector driving demand for decorative furnishings.
- Potential for strategic acquisitions to expand technology, market share, and geographic reach.
- Increased public and institutional awareness of hygiene and indoor air quality driving product adoption.
- Expansion into new residential markets for air purification solutions.
What Threats Does AUVI Face?
- Intense competition from established players in both the disinfection technology and furnishings markets.
- Economic downturns or recessions could significantly impact demand in the consumer cyclical hospitality segment.
- Rapid technological advancements by competitors could render existing solutions less competitive.
- Regulatory changes or new health standards could require costly product adaptations.
- Challenges in integrating acquired companies or technologies effectively.
What Are AUVI's Competitive Advantages?
- Proprietary science-based solutions for air purification (Airocide brand) and hard surface disinfection (Lumicide brand).
- Diversified revenue streams across two distinct segments: Disinfection and Hospitality.
- Established presence in multiple geographic markets including the U.S., Canada, and Europe.
- Ability to develop, acquire, and commercialize technology, suggesting a flexible innovation strategy.
- Specialization in fine decorative framed mirrors and bathroom vanities for the hospitality sector, catering to specific aesthetic and quality demands.
What Does AUVI Do?
Applied UV, Inc., established in 2019 and headquartered in Mount Vernon, New York, is a diversified technology company focused on developing, acquiring, and commercializing solutions for air purification and infection control. The company strategically addresses critical needs across various sectors, including healthcare, hospitality, commercial, municipal, and residential markets throughout the United States, Canada, and Europe. Its operations are distinctly segmented into Disinfection and Hospitality. Within the Disinfection segment, Applied UV, Inc. leverages proprietary science-based technologies to offer advanced air purification products under its Airocide brand. These solutions are designed to mitigate airborne pathogens and improve indoor air quality in sensitive environments. Complementing its air purification offerings, the company also provides products for the disinfection of hard surfaces, marketed under the Lumicide brand, catering to the ongoing demand for enhanced hygiene protocols. Beyond its infection control portfolio, Applied UV, Inc. maintains a significant presence in the Hospitality segment. Here, it specializes in the manufacturing and supply of fine decorative framed mirrors, framed arts, and bathroom vanities. This dual-segment approach allows the company to serve both essential health and safety needs and aesthetic demands within the consumer cyclical space, demonstrating a unique market positioning. The company's strategy involves both organic development and strategic acquisitions to expand its technological capabilities and market reach.
What Products and Services Does AUVI Offer?
- Develops and commercializes technology for air purification under the Airocide brand.
- Offers solutions for hard surface disinfection under the Lumicide brand.
- Manufactures and supplies fine decorative framed mirrors for the hospitality sector.
- Produces and distributes framed arts for hospitality and commercial clients.
- Supplies bathroom vanities, primarily for the hospitality industry.
- Serves healthcare, hospitality, commercial, municipal, and residential markets.
- Operates through two main segments: Disinfection and Hospitality.
- Conducts business in the United States, Canada, and Europe.
How Does AUVI Make Money?
- Generates revenue from the sale of air purification systems and related consumables.
- Sells hard surface disinfection products to various institutional and commercial clients.
- Derives revenue from the manufacturing and direct supply of decorative mirrors, framed art, and bathroom vanities to the hospitality industry.
- Utilizes a direct sales force and potentially distribution partners across its geographic markets.
- Focuses on both organic product development and strategic acquisitions to expand its technology portfolio and market reach.
What Industry Does AUVI Operate In?
Applied UV, Inc. operates within the broader Consumer Cyclical sector, specifically in the Furnishings, Fixtures & Appliances industry, while also having a significant presence in the health and safety technology market. The company's dual focus positions it uniquely. The infection control segment, encompassing air purification and surface disinfection, benefits from ongoing global health awareness and regulatory pushes for cleaner environments in healthcare, commercial, and public spaces. This market is experiencing sustained demand, driven by factors such as pandemic preparedness and increased focus on indoor air quality. Concurrently, its hospitality segment, which manufactures decorative mirrors and bathroom vanities, is tied to the cyclical nature of the construction, renovation, and leisure industries. This segment's performance is sensitive to economic conditions and consumer spending. Applied UV, Inc. competes with specialized technology firms in disinfection and established manufacturers in the furnishings space, requiring a robust strategy to maintain market share across its diverse offerings. The company's ability to leverage its 'science-based solutions' in disinfection could provide a competitive edge in a fragmented market.
Who Are AUVI's Key Customers?
- Healthcare facilities (hospitals, clinics) utilizing disinfection technologies.
- Hospitality establishments (hotels, resorts) purchasing furnishings and disinfection products.
- Commercial businesses (offices, retail spaces) seeking air purification and surface disinfection.
- Municipal entities (schools, public buildings) implementing infection control measures.
- Residential consumers interested in home air purification and decorative furnishings.
How Applied UV, Inc. Is Valued
Relative to its peer group, AUVI's quantitative score of 51/100 is roughly in line with the peer average of 51/100.
Company Profile
Applied UV, Inc. operates in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector. It is headquartered in Mount Vernon, US. The company is led by CEO Max Munn. AUVI has traded publicly since 2020.
ROE -63%Key Financial Metrics
Return on equity for Applied UV, Inc. stands at -62.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -22.6%, showing how much profit it generates from its asset base. A current ratio of 0.61 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
Applied UV, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.21 places it in the distress zone, a signal of elevated financial risk.
Net sellingInsider Activity
The most recent 11 insider filings for Applied UV, Inc. break down as 6 sales and 5 purchases. On net that is roughly 770K shares disposed (about $353.1B), a signal worth weighing alongside the fundamentals.
AUVI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- The social trading community seems to be buzzing about potential new contracts in the healthcare sector.
- There's a growing sentiment that AUVI's UV technology could see increased adoption due to heightened hygiene awareness.
- Market perception indicates a belief that AUVI is undervalued compared to its peers in the disinfection technology space.
Bear Case
- Recent community discussions highlight concerns about the company's ability to scale production to meet potential demand.
- Some investors are worried about increasing competition in the UV disinfection market.
- A segment of the social trading community expresses skepticism about the long-term viability of AUVI's business model.
- Market perception suggests that AUVI may face challenges in securing significant market share against established players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
AUVI Latest News
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · Sep 28, 2023
AUVI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AUVI.
Price Targets
Wall Street price target analysis for AUVI.
AUVI MoonshotScore
What does this score mean?
The MoonshotScore rates AUVI 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Furnishings, Fixtures & AppliancesLeadership: Max Munn
CEO
Unknown. Specific details regarding Max Munn's educational background, prior executive roles, or career progression before leading Applied UV, Inc. are not provided in the available source data. He is noted as managing 131 employees within the company, indicating a leadership role in overseeing the operational and strategic direction of the firm's dual segments in disinfection technology and hospitality furnishings.
Track Record: Max Munn has served as CEO since the company's incorporation in 2019. Under his leadership, Applied UV, Inc. has established its operational framework, developing and commercializing science-based air purification and disinfection technologies under the Airocide and Lumicide brands. He has also overseen the company's continued presence in the hospitality segment, manufacturing decorative mirrors and bathroom vanities, and expanding its market reach across the United States, Canada, and Europe.
Applied UV, Inc. Consumer Cyclical Stock: Key Questions Answered
What does the AI Score mean for AUVI?
AUVI holds an AI Score of 51/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Applied UV, Inc. develops and commercializes air purification and infection control technologies, alongside manufacturing decorative mirrors and bathroom vanities. The company serves healthcare …
What does Applied UV, Inc. do, and what are its primary market segments?
Applied UV, Inc. operates through two distinct segments: Disinfection and Hospitality. In its Disinfection segment, the company develops and commercializes science-based technologies for air purification under the Airocide brand and hard surface disinfection under the Lumicide brand. These solutions cater to critical needs in healthcare, commercial, municipal, and residential markets, focusing on improving hygiene and air quality.
What is AUVI's financial health given its market capitalization and profitability metrics?
Applied UV, Inc.'s financial health, based on the provided metrics, indicates significant challenges. The company currently operates with a negative profit margin of -32.4%, meaning it is not profitable and incurs losses relative to its revenue.
How does Applied UV, Inc. position itself in the competitive air purification and disinfection markets?
Applied UV, Inc. positions itself in the competitive air purification and disinfection markets by emphasizing its 'science-based solutions' under the Airocide and Lumicide brands. This focus on scientific efficacy aims to differentiate its products from generic alternatives, particularly in sensitive environments like healthcare facilities where performance is critical.
What are the primary growth strategies for Applied UV, Inc. in the coming years?
Applied UV, Inc.'s primary growth strategies revolve around leveraging its existing technological capabilities and market presence while pursuing strategic expansion. A key strategy involves capitalizing on the growing demand for air purification and disinfection solutions by expanding the reach of its Airocide and Lumicide brands into new segments and geographies.
What are the key factors to evaluate for AUVI?
Applied UV, Inc. (AUVI) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does AUVI data refresh on this page?
AUVI's price was last updated on Jul 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven AUVI's recent stock price performance?
Applied UV, Inc. (AUVI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model with two distinct segments: Disinfection and Hospitality. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AUVI overvalued or undervalued right now?
Applied UV, Inc. (AUVI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived strictly from the provided source data. No external information or speculation was used.
- The market capitalization of $0.00B is a direct quote from the source data and implies a very low or negligible valuation, which is a significant factor for investors.
- CEO background and track record details are limited due to the constraints of the provided source data, leading to 'Unknown' for specific background elements.